Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71−0.17 (-9.04%)
Close on Nov 20, 2026Market cap $2.72MP/E –Yield –
Silo Pharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Silo Pharma's gross profit for the twelve months ending Jun 30, 2026 was -$7.99K, down 112.1% year over year. For fiscal 2025 it was $27.81K, down 58.0% from the year before. The highest annual figure on record is $66.26K in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.81K | -58.0% |
| FY2024 | Dec 31, 2024 | $66.26K | 0.0% |
| FY2023 | Dec 31, 2023 | $66.26K | 0.0% |
| FY2022 | Dec 31, 2022 | $66.26K | +0.0% |
| FY2021 | Dec 31, 2021 | $66.26K | – |
| FY2020 | Dec 31, 2020 | -$135.20K | -1125.7% |
| FY2019 | Dec 31, 2019 | $13.18K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | -$2.66K | -116.1% |
| Q4 FY2025 | Dec 31, 2025 | -$2.66K | -116.1% |
| Q3 FY2025 | Sep 30, 2025 | -$2.66K | -116.1% |
| Q2 FY2025 | Jun 30, 2025 | $16.57K | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | $16.57K | -50.0% |
| Q4 FY2024 | Dec 31, 2024 | $16.57K | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $16.57K | 0.0% |
| Q4 FY2023 | Dec 31, 2023 | $16.57K | 0.0% |
| Q1 FY2023 | Jun 30, 2023 | $33.13K | +100.0% |
| Q4 FY2022 | Dec 31, 2022 | $16.57K | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $16.57K | 0.0% |
| Q2 FY2022 | Jun 30, 2022 | $16.57K | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | $16.57K | +0.0% |
| Q4 FY2021 | Dec 31, 2021 | $16.57K | – |
| Q3 FY2021 | Sep 30, 2021 | $16.57K | – |
| Q2 FY2021 | Jun 30, 2021 | $16.57K | +1776.1% |
| Q1 FY2021 | Mar 31, 2021 | $16.56K | +7787.1% |
| Q4 FY2020 | Dec 31, 2020 | -$123.13K | -1047.5% |
| Q3 FY2020 | Sep 30, 2020 | -$13.16K | -7177.4% |
| Q2 FY2020 | Jun 30, 2020 | $883 | – |
| Q1 FY2020 | Mar 31, 2020 | $210 | – |
| Q4 FY2019 | Dec 31, 2019 | $13.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $186 | – |
See a number that looks wrong?